Novartis Investigative Site

Goiânia 74605-070

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Multiple Sclerosis, Non-Small Cell Lung Cancer, Relapsing-remitting Multiple Sclerosis (RRMS)

Studies at this site

• Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis — Running, not enrolling
• Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer — Completed
• ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer — Stopped early
• MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone — Stopped early